Synthesis of novel triazoles bearing 1,2,4-oxadiazole and phenylsulfonyl groups by 1,3-dipolar cycloaddition of some organic azides and their biological activities
1,3-Dipolar cycloaddition of 5-azidomethyl-3-p-substituted phenyl-1,2,4-oxadiazoles to phenyl vinyl sulfone and bismaleimide gives rise straightforwardly to 1-((3-(p-substituted) phenyl-1,2,4-oxadiazol-5-yl)methyl)-4-(phenylsul\-fonyl)-4,5-dihydro-1H-1,2,3-triazoles and bisdihydropyrrolo[3,4-d][1,2,3]triazole-4,6(3aH,5H)-diones. The structures of the new cycloadducts were elucidated by means of IR, NMR (1H, 13C, 2D), mass spectra, and physical characteristics (mp and Rf values). In addition, anticancer activities of the cycloadducts against MCF-7 cells were also investigated.
Synthesis of novel triazoles bearing 1,2,4-oxadiazole and phenylsulfonyl groups by 1,3-dipolar cycloaddition of some organic azides and their biological activities
1,3-Dipolar cycloaddition of 5-azidomethyl-3-p-substituted phenyl-1,2,4-oxadiazoles to phenyl vinyl sulfone and bismaleimide gives rise straightforwardly to 1-((3-(p-substituted) phenyl-1,2,4-oxadiazol-5-yl)methyl)-4-(phenylsul\-fonyl)-4,5-dihydro-1H-1,2,3-triazoles and bisdihydropyrrolo[3,4-d][1,2,3]triazole-4,6(3aH,5H)-diones. The structures of the new cycloadducts were elucidated by means of IR, NMR (1H, 13C, 2D), mass spectra, and physical characteristics (mp and Rf values). In addition, anticancer activities of the cycloadducts against MCF-7 cells were also investigated.
___
- Ding, S.; Jia, G.; Sun, J. Angew. Chem. Int. Ed. 2014, 53, 1877–1880.
- Gao, J.; Zhang, X.; Xu, S.; Tan, F.; Li, X.; Zhang, Y.; Qu, Z.; Quan, X.; Liu, J. Chem. Eur. J. 2014, 20, 1957–1963.
- Rostovtsev, V. V.; Green, L. G.; Fokin, V. V.; Sharpless, K. B. Angew. Chem. Int. Ed. 2002, 41, 2596–2599.
- Himo, F.; Lovell, T.; Hilgraf, R.; Rostovtsev, V. V.; Noodleman, L.; Sharpless, K. B.; Fokin,V. V. J. Am. Chem.
- Soc. 2005, 127, 210–216.
- White, J. D.; Osborn, M. F.; Moghaddam, A. D.; Guzman, L. E.; Haley, M. M.; DeRose, V. J. J. Am. Chem.
- Soc. 2013, 135, 11680–11683.
- Fu, T-H.; Li, Y.; Thaker, H. D.; Scott, R. W.; Tew, G. N. ACS Med. Chem. Lett. 2013, 4, 841–845.
- Kushwaha, D.; Tiwari, V. K. J. Org. Chem. 2013, 78, 8184–8190.
- Thirumurugan, P.; Matosiuk, D.; Jozwiak, K. Chem. Rev. 2013, 113, 4905–4979.
- Li, X.; Tu, Z.; Li, H.; Liu, C.; Li, Z.; Sun, Q.; Yao, Y.; Liu, J.; Jiang, S. ACS Med. Chem. Lett. 2013, 4, 132–136.
- Suzuki, T.; Ota, Y.; Ri, M.; Bando, M.; Gotoh, A.; Itoh, Y.; Tsumoto, H.; Tatum, P. R.; Mizukami, T.; Nakagawa,
- H.; et al. J. Med. Chem. 2012, 55, 9562–9575.
- R. M.; De Oliveira, C. F.; Antunes, M. V.; Medeiros, E.; et al. Farmaco 2000, 55, 719–724. 27.Yang, X.; Liu, G.; Li, H.; Zhang, Y.; Song, D.; Li, C., Wang, R.; Liu, B.; Liang, W.; Jing, Y.; et al. J. Med. Chem.
- 2010, 53, 1015–1022. 28.Luthman, K.; Borg, S.; Hacksell, U. Methods Mol. Med. 1999, 23, 1–23. 29.Flipo, M.; Desroses, M.; Lecat-Guillet, N.; Villemagne, B.; Blondiaux, N.; Leroux, F.; Piveteau, C.; Mathys, V.;
- Flament, M-P.; Siepmann, J.; et al. J. Med. Chem. 2012, 55, 68–83. 30.Flipo, M.; Desroses, M.; Lecat-Guillet, N.; Dirie, B.; Carette, X.; Leroux, F.; Piveteau, C.; Demirkaya, F.; Lens,
- Z.; Rucktooa, P.; et al. J. Med. Chem. 2011, 54, 2994–3010. 31.Kale, P.; Johnson, L. B. Drugs Today 2005, 41, 91–105. 32.Torres, H. A.; Hachem, R. Y.; Chemaly, R. F.; Kontoyiannis, D. P.; Raad, I, I. Lancet Infect. Dis. 2005, 5, 775–785.
- Keating, G. M. Drugs 2005, 65, 1553–1567.
- Cuzick, J. Drugs Today 2005, 41, 227–239.
- Howell, A.; Buzdar, A. J. Steroid Biochem. Mol. Biol. 2005, 93, 237–247.
- Geisler, J.; Lİnning, P. E. J. Steroid Biochem. Mol. Biol. 2005, 95, 75–81. 37.Brueggemeier, R.W.; Hackett, J.C.; Diaz-Cruz, E. S. Endocr. Rev. 2005, 26, 331–345.
- Yin, L. M.; Wei, Y.; Wang, Y.; Xu, Y. D.; Yang Y. Q. Int. J. Med. Sci. 2013, 10, 68–72. 46.A˘gırba¸s, H.; S¨umengen, D.; D¨ur¨ust, Y.; D¨ur¨ust, N. Synth. Commun. 1992, 22, 209–217.